Hyperfine Inc. has announced results from the NEURO PMR study, which were presented at the American Society of Neuroimaging Annual Meeting in San Juan, Puerto Rico, on January 16, 2026. The study evaluated the clinical utility and patient experience of the portable Swoop® system, an FDA-cleared AI-powered portable MRI for brain imaging, compared to standard-of-care MRI in outpatient neurology clinics. The prospective, multi-center study enrolled 125 patients across DENT Neurologic Institute and Texas Neurology, including individuals with headache, dementia, multiple sclerosis follow-up, and tumor surveillance. Patients underwent brain imaging with both the Swoop® system and conventional high-field MRI, allowing for direct comparison between the modalities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyperfine Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260120756787) on January 20, 2026, and is solely responsible for the information contained therein.